Overview

Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of neuroprotection from granulocyte colony-stimulating factor on Parkinson disease
Phase:
Phase 2
Details
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Treatments:
Lenograstim
Neuroprotective Agents